Comprehensive investigation identifies CPSF3 as a novel prognostic and oncogenic biomarker in bladder cancer

Abstract Background Bladder cancer (BC) remains a prevalent malignancy worldwide, with rising incidence rates each year. Despite progress in therapeutic strategies, many patients suffer recurrence or progression, emphasizing the urgent need for novel prognostic biomarkers and therapeutic targets. Th...

Full description

Bibliographic Details
Published in:Discover Oncology
Main Authors: Zhiyang Ma, Yining Hao, Wei He, Xin Xie, Danfeng Xu, Chenghe Wang
Format: Article
Language:English
Published: Springer 2025-10-01
Subjects:
Bladder cancer
CPSF3 protein
Immunohistochemistry
Prognosis
Online Access:https://doi.org/10.1007/s12672-025-03672-z

Internet

https://doi.org/10.1007/s12672-025-03672-z

Similar Items